A subcutaneous xenograft mouse model of gallbladder cancer showed that lovastatin-induced HMGCR ablation inhibited tumor growth in vivo and promoted the efficacy of cisplatin, significantly prolonging the survival time of the mice [152]. Here, HMGCR is linked to neoplasm.